DNA Methylation and Chromatin Structure Changes Across 36 Cell Types in the Aging Mouse Brain
A cell type-specific view of brain aging
Reduced DNA methylation at transposable element regions was observed across several cell types in the aging mouse brain. Chromatin structure also showed changes, including stronger boundaries around domains. The Zeng team built a single-nucleus multi-omics atlas to analyze aging patterns by brain region and cell type. A research highlight published by Nature Genetics on April 15, 2026, reports the main findings of this study published in Cell.
Aging is accompanied by diverse epigenomic changes, but their detailed patterns in the brain remain insufficiently characterized. Chromatin changes are also associated with neurodegenerative diseases, although the mechanisms linking the two are not yet fully understood. This study examined these changes while distinguishing among the cell types and regions that make up the brain.
Changes in transposable element methylation and chromatin boundaries
The researchers mapped DNA methylation and chromatin structure across different brain regions. They combined these data with corresponding transcriptomic and chromatin accessibility datasets to analyze 36 major cell types in detail. This design enabled them to examine gene expression and epigenomic changes together.
DNA demethylation at transposable element regions emerged as a feature of aging across several cell types. In the aged brain, boundaries around topologically associating domains (TADs) were also stronger, and this was correlated with increased chromatin accessibility at CTCF binding sites. The published highlight does not describe this relationship as causal.
Spatial transcriptomic analysis revealed substantial differences across regions of the aged brain, even within the same cell type. This observation suggests that both cell type and spatial location should be considered. The researchers also presented a deep learning model that predicts changes in gene expression during aging from epigenomic data. However, the available highlight does not specify the model name, predictive performance, or detailed validation conditions.
Follow-up questions to investigate in human brains
This study provides data for examining epigenomic changes accompanying brain aging in the context of cell type and spatial location. Its value lies in capturing changes across multiple cell types alongside regional differences. Gene expression prediction illustrates one potential use of these data, but prediction does not establish the causes of aging or demonstrate treatment efficacy.
The Nature Genetics highlight specifically proposes follow-up studies in human brains, including samples from people with neurodegenerative diseases. Whether the changes observed in mice are also found in humans, and how they are mechanistically linked to disease, remain to be investigated. The available materials do not demonstrate memory restoration or dementia prevention.
This article is based on the Nature Genetics research highlight. The full text and supplementary materials of the original Cell paper cited in the highlight were not included in the materials reviewed for this article.
Nature Genetics, Published online: 15 April 2026; doi:10.1038/s41588-026-02590-2Chromatin remodeling during brain aging
This atlas could serve as a starting point for comparisons in studies of human brain aging and neurodegenerative diseases. For example, researchers could examine human brain samples by cell type and region to see whether the reduced transposable element methylation and chromatin boundary changes observed in mice are also present. The finding of regional differences within the same cell type provides a reason to consider the spatial context of samples. This is a potential use in future research; it does not establish a validated diagnostic marker or therapeutic target. Assessing the potential for clinical application will require confirming reproducibility in human samples and a mechanistic link to disease.